T-CELL PROLYMPHOCYTIC LEUKAEMIA

This adverse event was reported 93 times

These drugs are most commonly taken by patients reporting T-CELL PROLYMPHOCYTIC LEUKAEMIA:

# Drug Count
0 ALEMTUZUMAB 34
1 VENETOCLAX 28
2 CYCLOPHOSPHAMIDE 27
3 CYCLOPHOSPHAMIDE FOR INJECTION 27
4 CYCLOPHOSPHAMIDE INJECTION, SOLUTION 27
5 PREDNISONE 14
6 FLUDARABINE PHOSPHATE 13
7 CYCLOSPORINE 11
8 DOXORUBICIN 10
9 MYCOPHENOLATE MOFETIL 10
See all common drugs associated with T-CELL PROLYMPHOCYTIC LEUKAEMIA

T-CELL PROLYMPHOCYTIC LEUKAEMIA is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 PENTOSTATIN 6 0.0057
1 ALEMTUZUMAB 34 0.0018
2 FLUMAZENIL 1 0.0011
3 NELARABINE 1 0.0010
4 MITOXANTRONE HYDROCHLORIDE 5 0.0008
5 ACYCLOVIR SODIUM 1 0.0008
6 CLADRIBINE 7 0.0007
7 CIDOFOVIR ANHYDROUS 1 0.0007
8 ROMIDEPSIN 1 0.0006
9 VENETOCLAX 28 0.0004
See all drugs enriched for association with T-CELL PROLYMPHOCYTIC LEUKAEMIA